3 appearances on JRE

Rick Doblin

Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated Lykos Therapeutics (formerly MAPS Public Benefit Corporation) which is leading drug development of MDMA-assisted therapy for PTSD.

Books and Products

Things mentioned across Rick Doblin's JRE appearances — linked to Amazon.

Psychedelic Science 2025 Conference

Amazon

Major international conference showcasing latest psychedelic research, clinical breakthroughs, and bringing together scientists, therapists, and advocates in Denver June 16-20.

MAPS (Multidisciplinary Association for Psychedelic Studies)

Amazon

Nonprofit organization conducting clinical research on psychedelic-assisted therapy for PTSD and other conditions.

MAPS Public Benefit Corporation

Amazon

The pharmaceutical arm of MAPS wholly owned by the nonprofit, developing MDMA-assisted therapy for prescription use.

As an Amazon Associate we earn from qualifying purchases.

All JRE Appearances (3)

JRE 2319 - Rick Doblin
JRE 2319

Rick Doblin

May 9, 2025

Rick Doblin discusses MAPS' mission to advance psychedelic-assisted therapy and end prohibition through evidence-based research

JRE 1964 - Rick Doblin
JRE 1964

Rick Doblin

June 27, 2024

Rick Doblin founded MAPS in 1986 and has spent nearly 40 years getting MDMA-assisted therapy approved for PTSD treatment

JRE 1661 - Rick Doblin
JRE 1661

Rick Doblin

June 27, 2024

Rick Doblin founded MAPS to legitimize psychedelic research through rigorous scientific studies and FDA approval pathways

← All Guests